Literature DB >> 33654793

A High-throughput qPCR-based Method to Genotype the SOD1G93A Mouse Model for Relative Copy Number.

Valerie R Tassinari1, Fernando G Vieira1.   

Abstract

The most commonly used mouse model in ALS preclinical research expresses multiple copies of the human SOD1 (G93A) transgene. During the course of breeding, successive generations of mice can lose copies of the transgene. Because shorter lifespan of these mice is dependent on transgene copy number, it is essential to ensure that no low-copy, and therefore longer-lived, mice are included in preclinical studies. Existing techniques for SOD1G93A mouse genotyping are broadly based on creating a standard curve using a reference gene and deducing the relative amount of SOD1 by comparison with the standard curve. This type of technique is used in Alexander et al. (2004) , Vieira et al. (2017) and Maier et al. (2018) . However, it is not described in detail (see Note 1). This paper provides a detailed protocol for determining the relative copy number of the human SOD1 transgene. Briefly, the protocol involves first the extraction of high-quality genomic DNA from mouse ear tissue, creation of a genomic DNA concentration-based standard curve, and qPCR analysis of up to 88 samples at once alongside the standard curve with Gapdh as a reference gene. Analysis involves the normalization of each unknown sample using the standard curve followed by determination of the copy number of the sample relative to the cohort median. This protocol has been optimized to produce high-quality genomic DNA and consistent results, and the relative copy number cutoffs have been optimized and validated empirically by comparison of relative copy number and mouse lifespan.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  ALS mouse model; High-throughput genotyping; Mouse genotyping; Preclinical research; Relative copy number; SOD1; Transgene copy number

Year:  2019        PMID: 33654793      PMCID: PMC7854241          DOI: 10.21769/BioProtoc.3276

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  5 in total

1.  A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.

Authors:  Marcel Maier; Tobias Welt; Fabian Wirth; Fabio Montrasio; Daniel Preisig; Jordan McAfoose; Fernando G Vieira; Luka Kulic; Claudia Späni; Thilo Stehle; Steve Perrin; Markus Weber; Christoph Hock; Roger M Nitsch; Jan Grimm
Journal:  Sci Transl Med       Date:  2018-12-05       Impact factor: 17.956

2.  Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS.

Authors:  Guillermo M Alexander; Kirsten L Erwin; Nathaniel Byers; Jeffrey S Deitch; Brian J Augelli; Elizabeth P Blankenhorn; Terry D Heiman-Patterson
Journal:  Brain Res Mol Brain Res       Date:  2004-11-04

3.  CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits.

Authors:  Fernando G Vieira; Theo Hatzipetros; Kenneth Thompson; Andy J Moreno; Joshua D Kidd; Valerie R Tassinari; Beth Levine; Steven Perrin; Alan Gill
Journal:  IBRO Rep       Date:  2017-03-12

Review 4.  Animal models of amyotrophic lateral sclerosis: A comparison of model validity.

Authors:  Jessica R Morrice; Cheryl Y Gregory-Evans; Christopher A Shaw
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

5.  Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents.

Authors:  Pierre Zwiegers; Grace Lee; Christopher A Shaw
Journal:  J Negat Results Biomed       Date:  2014-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.